Thanachart Capital PCL buy krebskrebs
Start price
27.07.20
/
50%
€0.90
Target price
04.11.21
€1.40
Performance (%)
1.11%
End price
05.11.21
€0.91
Summary
This prediction ended on 05.11.21 with a price of €0.91. With a performance of 1.11%, the BUY prediction by krebskrebs for Thanachart Capital PCL closed with a slight gain. A total of €0.033 was paid as dividends for this prediction. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Thanachart Capital PCL | -0.840% | -0.840% | -9.924% | 36.416% |
| iShares Core DAX® | -0.205% | 2.949% | 17.330% | 18.203% |
| iShares Nasdaq 100 | 1.613% | 5.877% | 37.451% | 56.281% |
| iShares Nikkei 225® | -0.740% | -1.256% | 11.847% | 5.531% |
| iShares S&P 500 | 0.267% | 3.240% | 29.308% | 46.371% |
Comments by krebskrebs for this prediction
In the thread Thanachart Capital PCL diskutieren
In the thread Trading Thanachart Capital PCL
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten